Results 21 to 30 of about 674,551 (249)
The Lifespan of Bioprosthetic Valves: Improving Durability Through Biofunctionalization. [PDF]
Sellers SL, Quine E.
europepmc +2 more sources
Background: The choice between bioprosthetic and mechanical valves for aortic valve replacement (AVR) and mitral valve replacement (MVR) among patients aged 50–70 years is controversial.
Wei Zhao +9 more
doaj +1 more source
Performance of xenogeneic pulmonary visceral pleura as bioprosthetic heart valve cusps in swine
ObjectiveBovine pericardium is common biological material for bioprosthetic heart valve. There remains a significant need, however, to improve bioprosthetic valves for longer-term outcomes.
Xiao Lu +5 more
doaj +1 more source
BACKGROUND The optimal anticoagulation strategy for patients with bioprosthetic valves and atrial fibrillation remains uncertain. We conducted a meta-analysis using updated evidence comparing direct anticoagulants (DOACs) and vitamin K antagonists (VKAs)
Y. Yokoyama +7 more
semanticscholar +1 more source
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
AIMS Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are increasingly performed. There are no data on long-term outcomes after aortic ViV.
S. Bleiziffer +74 more
semanticscholar +1 more source
Dynamic Echocardiographic Imaging of a Valve-in-Valve Mitral Prosthesis
Dynamic imaging of heart valves and specifically prosthetic valves is a central benefit of echocardiography. Most bioprosthetic heart valves degenerate over a given time and hence require repeat valve replacement which carries a significant risk of ...
Bishoy Wassef +4 more
doaj +1 more source
Background: None of the currently available prosthetic valves are comparable to native valves in hemodynamic functions. One has to choose between durability, thrombogenicity, or risk of major bleeds.
Mandeep Singh Sondh +3 more
doaj +1 more source
Bioprosthetic valve fracture: a practical guide [PDF]
Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) is currently indicated for the treatment of failed surgical tissue valves in patients determined to be at high surgical risk for re-operative surgical valve replacement. VIV TAVR, however, often results in suboptimal expansion of the transcatheter heart valve (THV) and can result in ...
Keith B, Allen +7 more
openaire +3 more sources
BACKGROUND Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed tomography (CT), may represent a form of bioprosthetic valve dysfunction.
R. Makkar +24 more
semanticscholar +1 more source
With the aging of the population in worldwide, valvular heart disease has become one of the most prominent life-threatening diseases in human health, and heart valve replacement surgery is one of the therapeutic methods for valvular heart disease ...
Qi Tong +6 more
doaj +1 more source

